Henry Schein (NASDAQ:HSIC) Shares Gap Down – Here’s Why

Posted by Francis Steltz on Oct 8th, 2026

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report)’s share price gapped down prior to trading on Thursday. The stock had previously closed at $83.66, but opened at $79.95. Henry Schein shares last traded at $82.6010, with a volume of 366,651 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on HSIC shares. Citigroup reaffirmed a “buy” rating and set a $112.00 price target (up from $100.00) on shares of Henry Schein in a research report on Wednesday, August 5th. Weiss Ratings raised shares of Henry Schein from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, August 21st. Barrington Research set a $104.00 target price on shares of Henry Schein in a research report on Wednesday, August 5th. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Monday, August 17th. Finally, BMO Capital Markets began coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They issued a “market perform” rating and a $85.00 price target for the company. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.93.

Get Our Latest Analysis on HSIC

Henry Schein Stock Down 0.8%

The company has a current ratio of 1.32, a quick ratio of 0.73 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $9.25 billion, a P/E ratio of 24.12, a PEG ratio of 1.50 and a beta of 0.84. The stock has a 50 day moving average price of $87.73 and a 200 day moving average price of $81.66.

Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.03. The business had revenue of $3.46 billion during the quarter, compared to the consensus estimate of $3.37 billion. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.Henry Schein’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 5.36 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Southpoint Capital Advisors LP grew its holdings in shares of Henry Schein by 28.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock valued at $235,840,000 after buying an additional 700,000 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Henry Schein by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company’s stock worth $211,734,000 after acquiring an additional 56,687 shares during the last quarter. M.D. Sass LLC lifted its position in Henry Schein by 2.9% in the 1st quarter. M.D. Sass LLC now owns 1,273,316 shares of the company’s stock valued at $93,843,000 after acquiring an additional 35,443 shares in the last quarter. Bank of America Corp DE lifted its position in Henry Schein by 5.9% in the 1st quarter. Bank of America Corp DE now owns 1,221,585 shares of the company’s stock valued at $90,031,000 after acquiring an additional 68,593 shares in the last quarter. Finally, Defilade Capital Management L.P. boosted its stake in Henry Schein by 94.8% during the 1st quarter. Defilade Capital Management L.P. now owns 624,037 shares of the company’s stock valued at $45,992,000 after purchasing an additional 303,615 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc (NASDAQ: HSIC) is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.